from Patricia: I love what Dr. Friedman has to say here about the behavior of Gilead and BMS in light of the excellent trials results released yesterday at the International Liver Conference. He has hit the nail on the head. They are playing with people’s lives here …
Submitted by Annabel Tautou on Fri, 04/20/2012 - 07:57
It has been recently revealed in a report that there has been a new drug combination made that can effectively treat hepatitis C in the time to come. This has even proved to work well in a small scale trial. This means that in the time to come, it might surely be able to prove its worth as a potential way to treat or at least work towards securing the body, when it comes to the affliction of this disease.
“The only appropriate motivation should be what is the best and fastest way to get cures, not what is best for the shareholders”, revealed Dr. Scott Friedman, chief of liver diseases at the Mount Sinai School of Medicine in New York.
Though it is too early to jump to any conclusions as of now, it might still be a very positive step in the time to come. It might be able to form an effective way to cure the disease and might even prevent it from occurring in the time to come.
There are currently a number of companies trying their best to formulate such medicines that work towards eradicating this disease from the world. There is however need for more efforts to be made by one and all for collectively being able to fight the disease in the time to come, rather than fighting on which company has been able to form the drug.
The cure percentage for the drug has been greatly improved by the introduction of the pills by Vertex Pharmacy firm, which gave out its drug last year. It remains to be seen how the firms trying to develop cures shall be able to find it in the time to come and how cure methods can be made better for the disease.
Also See:
No comments:
Post a Comment